贾德安,周玉杰,史冬梅,赵迎新,杨士伟,刘晓丽,胡宾

• 1:首都医科大学附属北京安贞医院

摘要(Abstract)：

目的桡动脉痉挛是经桡动脉介入诊疗中最常见的并发症。本研究初步探讨血管活性物质和桡动脉痉挛的关系,为临床桡动脉痉挛的预防提供理论依据。方法本研究为前瞻性、配对病例对照研究。所有患者均为仅接受经桡动脉冠状动脉造影的患者,按照性别相同,年龄相差2岁以内进行1:2配对。痉挛的判断使用临床桡动脉痉挛的定义。检测两组患者血清一氧化氮、内皮素-1、前列环素、血栓素A2、去甲肾上腺素浓度,并多因素回归分析桡动脉痉挛发生的危险因素。结果入选60例发生桡动脉痉挛的单纯冠状动脉造影患者,配对入选120例未发生桡动脉痉挛的单纯冠状动脉造影患者。痉挛组和对照组中一氧化氮[(63.5875±21.2763)μmol/L比(55.6425±18.1542)μmol/L,F=7.442,P=0.351]和血栓素A2[(0.9768±0.1953)ng/ml比(0.7824±0.2051)ng/ml,F=1.058,P=0.284]浓度差别没有统计学意义,内皮素-1[(298.5839±65.3291)ng/ml比(81.4391±20.4283)ng/ml,F=2.034,P<0.001]和去甲肾上腺素[(202.3721±38.3829)ng/ml比(56.4828±15.6025)ng/ml,F=39.267,P=0.005]高于对照组,前列环素[(8.8294±2.5322)pg/ml比(15.5430±4.8267)pg/ml,F=14.586,P=0.038]低于对照组。多因素回归分析发现,内皮素-1(OR2.954,95%CI1.569～5.354,P=0.005)和去甲肾上腺素(OR4.642,95%CI2.619～8.332,P=0.018)是术中发生桡动脉痉挛的危险因素。结论内皮素-1和去甲肾上腺素浓度是术中桡动脉痉挛发生的危险因素。

关键词(KeyWords)： 桡动脉痉挛;内皮缩血管肽1;去甲肾上腺素

Abstract:

Keywords:

基金项目(Foundation): 首都医科大学附属北京安贞医院院长科技发展基金(2010)

作者(Author): 贾德安,周玉杰,史冬梅,赵迎新,杨士伟,刘晓丽,胡宾

参考文献(References)：

• [1]Ruiz-Salmeron RJ,Mora R,Masotti M,et al.Assessment of the efficacy of phentolamine to prevent radial artery spasm during cardiac catheterization procedures:a randomized study comparing phentolamine vs.verapamil.Catheter Cardiovasc Interv,2005,66:192-198.
• [2]Kim SH,Kim EJ,Cheon WS,et al.Comparative study of nicorandil and a spasmolytic cocktail in preventing radial artery spasm during transradial coronary angiography.Int J Cardiol,2007,120:325-330.
• [3]He GW,Yang CQ.Comparison among arterial grafts and coronary artery.An attempt at functional classification.J Thorac Cardiovasc Surg,1995,109:707-715.
• [4]Brunner F,Bras-Silva C,Cerdeira AS,et al.Cardiovascular endothelins:essential regulators of cardiovascular homeostasis.Pharmacol Ther,2006,111:508-531.
• [5]Bian K,Doursout MF,Murad F.Vascular system:role of nitric oxide in cardiovascular diseases.J Clin Hypertens(Greenwich),2008,10:304-310.
• [6]Desjardins F,Balligand JL.Nitric oxide-dependent endothelial function and cardiovascular disease.Acta Clin Belg,2006,61:326-334.
• [7]Gryglewski RJ.Prostacyclin among prostanoids.Pharmacol Rep,2008,60:3-11.
• [8]Dogne JM,de Leval X,Hanson J,et al.New developments on thromboxane and prostacyclin modulators part I:thromboxane modulators.Curr Med Chem,2004,11:1223-1241.
• [9]Lyssand JS,DeFino MC,Tang XB,et al.Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome.J Biol Chem,2008,283:18792-18800.
• [10]Conant AR,Shackcloth MJ,Oo AY,et al.Phenoxybenzamine treatment is insufficient to prevent spasm in the radial artery:the effect of other vasodilators.J Thorac Cardiovasc Surg,2003,126:448-454.
• [11]Jia DA,Zhou YJ,Shi DM,et al.Incidence and predictors of radial artery spasm during transradial coronary angiography and intervention.Chin Med J(Engl),123:843-847.